Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide in Males With COVID-19
NCT04509999Phase 3Withdrawn
- Sponsor
- University of Florida
- Start
- Oct 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bicalutamide in coronavirus disease 2019 (COVID-19), sponsored by University of Florida. Planned start Oct 2020; status: withdrawn.
02
Drugs
bicalutamide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04509999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509999.